Zimmer Biomet Leads Surgical Equipment Earnings with 9.3% Revenue Growth

Earnings
โดย Yahoo Finance·Read original
Summary · why it matters

Zimmer Biomet reported first-quarter revenues of $2.09 billion, up 9.3% year on year, making it the fastest-growing company among five surgical equipment and consumables stocks tracked. The result exceeded analysts' expectations by 0.9%, and the company also beat earnings per share estimates and full-year EPS guidance. CONMED posted revenues of $317 million, down 1.3% year on year but beating estimates by 2.1%, the largest beat in the group. STERIS reported $1.59 billion in revenues, up 7.3% and in line with expectations, while BD's revenues rose 5.2% to $4.71 billion, topping estimates by 0.8%. Solventum's revenues declined 3.1% to $2.01 billion, surpassing estimates by 1.9% but recording the slowest revenue growth among the peers.

Impact on stocks 5

Health Care▲ · 2 stocks
CONMED Corporation
CNMD
▲ PositiveCapitalrelevance

CONMED posted revenues of $317M, down 1.3% YoY but beating estimates by 2.1%, the largest beat in the group.

STERIS plc
STE
± MixedCapitalrelevance

STERIS reported $1.59B in revenues, up 7.3% and in line with expectations, no surprise.

Robotics & Physical AI▲ · 1 stocks
Zimmer Biomet Holdings Inc
ZBH
▲ PositiveCapitalrelevance

Zimmer Biomet reported Q1 revenues of $2.09B, up 9.3% YoY, beating estimates by 0.9%, and also beat EPS and full-year guidance.

Aging Population▼ · 1 stocks
Solventum Corp.
SOLV
▼ NegativeCapitalrelevance

Solventum's revenues declined 3.1% to $2.01B, the slowest revenue growth among peers.

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketDXNews